AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Empride 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Freedom Healthcare Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Empride 1mg/500mg Tablet ER

Diabeticare Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabeticare Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your doctor, are necessary.

Primary Ingredients of Empride 1mg/500mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Empride 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Empride 1mg/500mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Empride 1mg/500mg Extended-Release tablet should be taken with a meal.

Common Side effects of Empride 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Empride 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume the Empride 1mg/500mg Extended-Release tablet with food.

How Empride 1mg/500mg Tablet ER works:

Empride ER tablets (1mg/500mg) contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Empride 1mg/500mg extended-release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Empride 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks prior to prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Empride tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

For individuals with kidney impairment, Empride 1mg/500mg Extended-Release tablets require careful administration. Dosage modification of Empride 1mg/500mg Extended-Release tablets may be necessary. Physician consultation is recommended. In cases of severe kidney disease, the use of Empride 1mg/500mg Extended-Release tablets is contraindicated. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Empride 1mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, Empride 1mg/500mg ER tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Empride 1mg/500mg Tablet ER :

Should you forget to take a scheduled Empride 1mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Empride 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Empride 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Empride 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Empride 1mg/500mg Tablet ER and seek immediate medical attention.
Empride 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Empride is not suitable for type 1 diabetes.
Empride 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Empride 1mg/500mg Tablet ER can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Empride 1mg/500mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Empride 1mg/500mg ER tablets and alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Empride 1mg/500mg Tablet ...
49
MRP 60
18% off